Immunic, inc. announces promotion of glenn whaley, cpa to chief financial officer

New york , march 16, 2022 /prnewswire/ -- immunic, inc.  (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced that glenn whaley, cpa, who has served as vice president finance, principal financial and accounting officer since april 2020, has been promoted to the position of chief financial officer. "glenn has done an outstanding job since joining the company in 2019 and his more than 30 years of experience in accounting and finance have been invaluable to the smooth running of our u.s. operations as we have continued to progress our pipeline and pursue the many opportunities before us," commented daniel vitt, ph.d.
IMUX Ratings Summary
IMUX Quant Ranking